Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
about
Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@en
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@nl
type
label
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@en
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@nl
prefLabel
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@en
Dual sphingosine kinase inhibi ...... tin and FAK/IGF-1R signalling.
@nl
P50
P1476
Dual sphingosine kinase inhibi ...... ntin and FAK/IGF-1R signalling
@en
P2093
Ivana Tomljanović
Ksenija Lučin
P304
P356
10.1016/J.BBRC.2017.04.100
P407
P577
2017-04-19T00:00:00Z